Pain Management FAQs: Mastering the Art of Treating Pain 2024-2025
Webcast
0.5 AMA PRA Category 1 Credit™ ...Faculty
OVERVIEW
Pain Management FAQs: Mastering the Art of Treating Pain is organized by Pri-Med.
Release Date: 11/01/2024
Expiration Date: 12/01/2025
Description:
Clinicians who manage patients with painful conditions have many practical questions regarding the various treatment modalities—ranging from nonpharmacologic options to non-opioid therapies and opioid prescribing; they also seek information on the identification of risk for opioid use disorder (OUD) along with the management and referral of patients with OUD. In this activity, Dr. Katherine Galluzzi addresses many questions that participants in Pri-Med CE/CME activities on pain management have asked, providing practical and actionable answers.
Learning Objectives:
- Identify risk factors and stratification for opioid-related aberrant behavior and opioid use disorder as part of the initial assessment
- Identify strategies for ongoing, safe, and effective use of opioids in patients with chronic pain, including titration, referral, and discontinuation, when appropriate
- Act appropriately to evaluate, treat, or refer patients with opioid use disorder
Topics
- MATE Act
- Controlled Substances
- Controlled Substances - Drug Diversion
- Medical Ethics & Legal Issues - Risk Management
- Controlled Substances - PDMP
- Controlled Substances - Prescribing
- Controlled Substances - Schedule II/III
- Non-pharmacologic Pain Management & Implantable Devices
- Opioids
- Opioids - Addiction
- Opioids - Opioid Antagonists
- Opioids - Prescribing
- Pain Management
- Psychiatry & Behavioral Health - Addiction
- Psychiatry & Behavioral Health - Substance Abuse
- Psychiatry & Behavioral Health - Substance Use Disorder
- Psychiatry & Behavioral Health - Addiction - KY Board Approved (PA)
- Controlled Substances - Prescribing - KY Board Approved HB1
- Controlled Substances - KY Board Approved (PA)
ACCREDITATION & CREDITS
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.
Designation Statement
This activity is approved for 0.5 contact hour of continuing education, which includes 0.25 hours of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
TARGET AUDIENCE
PhysicianPharmacistPain ManagementPsychiatristsBehavioral Health NursesSPECIALITIES
Pain ManagementBehavioral HealthPsychiatry
Quick Links